Daniella Livnat

Evaluation of Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Primary Isolates by Neutralization Assays: Performance Criteria for Selecting Candidate Antibodies for Clinical Trials

M. Patricia D’Souza, Daniella Livnat, James A. Bradac et al. · The Journal of Infectious Diseases · 1997 · 147 citations · Full text

Pharmacy, Immunology, Infectious Diseases +15

Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu.

D W Scott, Daniella Livnat, Christopher A. Pennell et al. · The Journal of Experimental Medicine · 1986 · 111 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Lymphoma models for B-cell activation and tolerance

David W. Scott, Jane S. Tuttle, Daniella Livnat et al. · Cellular Immunology · 1985 · 69 citations

Life Sciences, Hematology, Immunology +14

Three-color supplement to the NIAID DAIDS guideline for flow cytometric immunophenotyping

Janet K.A. Nicholson, Pamela G. Kidd, Francis Mandy et al. · Cytometry · 1996 · 66 citations

Life Sciences, Hematology, Immunology +9

Use of CD45 gating in three and four‐color flow cytometric immunophenotyping: Guideline from the national institute of allergy and infectious diseases, division of AIDS

Carol Schnizlein‐Bick, Francis Mandy, Maurice R.G. O’Gorman et al. · Cytometry · 2002 · 57 citations

Life Sciences, Hematology, Immunology +13